Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder, characterized by proliferation of granulocytes, caused by a translocation that produces the Philadelphia chromosome resulting in constitutively active BCR-ABL tyrosine kinase. Imatinib and dasatinib are 2 BCR-ABL tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autor principal: Ryan, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
JOURNAL WATCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113552/
https://www.ncbi.nlm.nih.gov/pubmed/30167550
http://dx.doi.org/10.1016/j.jacbts.2016.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113552/
https://www.ncbi.nlm.nih.gov/pubmed/30167550
http://dx.doi.org/10.1016/j.jacbts.2016.11.005

Ejemplares similares